5VH5
Crystal Structure of Fc fragment of anti-TNFa antibody infliximab
Summary for 5VH5
Entry DOI | 10.2210/pdb5vh5/pdb |
Related | 5VH3 5VH4 |
Descriptor | Infliximab Fc, beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ZINC ION, ... (5 entities in total) |
Functional Keywords | antibody, fc, biosimilar, infliximab, tnfa, anti-tnfa, immune system |
Biological source | Mus musculus, Homo sapiens |
Total number of polymer chains | 1 |
Total formula weight | 30038.82 |
Authors | Mayclin, S.J.,Edwards, T.E.,Lerch, T.F.,Conlan, H.,Sharpe, P. (deposition date: 2017-04-12, release date: 2017-05-03, Last modification date: 2023-10-04) |
Primary citation | Lerch, T.F.,Sharpe, P.,Mayclin, S.J.,Edwards, T.E.,Lee, E.,Conlon, H.D.,Polleck, S.,Rouse, J.C.,Luo, Y.,Zou, Q. Infliximab crystal structures reveal insights into self-association. MAbs, 9:874-883, 2017 Cited by PubMed: 28421849DOI: 10.1080/19420862.2017.1320463 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.75 Å) |
Structure validation
Download full validation report